e-learning
resources
London 2016
Monday, 05.09.2016
Pulmonary hypertension: the clinic II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
miR-424 and muscle wasting in pulmonary arterial hypertension
Benjamin Garfield (London, United Kingdom), Martin Connolly, Benjamin Garfield, Alexi Crosby, Peiran Yang, Nicholas Morrell, Michael Polkey, S. John Wort, Paul Kemp
Source:
International Congress 2016 – Pulmonary hypertension: the clinic II
Session:
Pulmonary hypertension: the clinic II
Session type:
Thematic Poster
Number:
2412
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Benjamin Garfield (London, United Kingdom), Martin Connolly, Benjamin Garfield, Alexi Crosby, Peiran Yang, Nicholas Morrell, Michael Polkey, S. John Wort, Paul Kemp. miR-424 and muscle wasting in pulmonary arterial hypertension. Eur Respir J 2016; 48: Suppl. 60, 2412
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension
Source: Eur Respir J 2015; 45: 1737-1740
Year: 2015
IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Peripheral and respiratory muscle strength in pulmonary artery hypertension
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Inspiratory muscle training in pulmonary hypertension
Source: Annual Congress 2013 –Rehabilitation, exercise and adjunct physiotherapy techniques in different respiratory conditions
Year: 2013
The role of growth and differentiation factor 15 (GDF-15) in the development of skeletal muscle wasting in pulmonary arterial hypertension (PAH)
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Influence of inspiratory muscle weakness in exercise capacity of patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016
Impairment of respiratory muscle function in pulmonary hypertension
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007
Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Anti-fibrotic effects of pirfenidone on pulmonary arterial vascular smooth muscle cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Smooth muscle microparticles as novel biomarkers of vascular remodelling and inflammation in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension
Source: ERJ Open Res, 7 (3) 00449-2021; 10.1183/23120541.00449-2021
Year: 2021
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease and coronary artery disease
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Is systemic oxygen extraction on exercise impaired in pulmonary arterial hypertension?
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Uric acid causes excessive pulmonary arterial smooth muscle cell proliferation via URATv1 upregulation in pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Quadriceps dysfunction in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept